Skip to main content
. 2022 Jul 7;23(14):7535. doi: 10.3390/ijms23147535

Figure 2.

Figure 2

(A) First PROTACs to enter in-human clinical trials (https://www.guidetopharmacology.org (accessed on 1 March 2022)). (B) Examples of reported bifunctional hydrophobically tagged molecules. (C) Reported HDAC8 PROTAC.